Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2008 Results
Date:7/17/2008

GLENWOOD, Ill., July 17 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal third quarter of 2008 pre-market on Tuesday, July 29, 2008.

The company will host a conference call for investors on Tuesday, July 29, 2008, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 800-366-7640 (within the United States and Canada), or 303-262-2137 (international callers), or by visiting the "Investors" page on the company's website at http://www.landauerinc.com. Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-405-2236 (within the United States and Canada), or 303-590-3000 (international callers), passcode 11117488#, which will be available through Friday, August 29, 2008. The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.

For the latest news releases and other corporate documents on Landauer Inc., visit http://www.landauerinc.com


'/>"/>
SOURCE Landauer, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Genmab A/S - Company Announcement
2. Advanced Life Sciences to Host Conference Call to Discuss Announcement Made Yesterday by FDA to Conduct Advisory Panel on CAP Drug Development
3. Announcement in Relation to the Movement in the ClinPhone Share Price
4. First Quarter 2008 Financial Results Announcement and Teleconference
5. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
6. Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLCs Regulatory Announcement
7. Exiqon: Major Shareholder Announcement
8. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
9. CNS Response Announces Fiscal Third Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):